The Australian Pesticides and Veterinary Medicines Authority (APVMA) has announced a reconsideration of chlorpyrifos-methyl, which will include all products containing chlorpyrifos-methyl, associated label approvals and the approvals of chlorpyrifos-methyl as an active constituent.
Chlorpyrifos-methyl was prioritised for reconsideration based on the potential for toxic impurities in the active constituent, and potential risks posed by the use of the chemical products to human health, (worker health and safety, and dietary exposure) the environment and international trade.
None of the information currently available to the APVMA indicates an imminent risk that would require immediate regulatory action. The APVMA has the power to take quick action should new evidence emerge that shows an imminent risk to human health.
A public consultation on the scope and reasons for the reconsideration is currently open, and submissions will be accepted until 8 September 2026.
The time frame for the reconsideration is 42 months which commences at the close of consultation, however a decision may be taken earlier if all assessments are completed.
Media enquiries: APVMA Media | +61 2 6770 2402 | media@apvma.gov.au